• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
TechAI

Exclusive: Andreessen Horowitz just invested in this A.I. health care startup

By
Jonathan Vanian
Jonathan Vanian
Down Arrow Button Icon
By
Jonathan Vanian
Jonathan Vanian
Down Arrow Button Icon
May 11, 2021, 8:00 AM ET

Investors are betting that the health care industry will increasingly adopt artificial intelligence to improve patient care.

Venture capital giant Andreessen Horowitz has led a $10.5 million investment in the startup Memora Health, the two firms announced on Tuesday. Other participating investors include venture fund AlleyCorp, Martin Ventures, Operator Partners, and Thirty Five Ventures, the venture fund of NBA star Kevin Durant and his manager, Rich Kleiman.

Memora Health specializes in machine learning that analyzes health care data so that doctors can better care for patients after their visits and hospital stays, said the startup’s cofounder and CEO, Manav Sevak. 

Memora Health’s software would help doctors send specific messages tailored to mothers who have been recently discharged from the hospital after giving birth, for instance. These messages, often sent via text, could include surveys that screen for postpartum depression or provide information about what to expect from their newborns in the coming weeks.

The idea is that health care providers can proactively send relevant information to patients who may have otherwise searched for information online or relied on word of mouth, Sevak said. Patients must opt in to receive the messages, and the startup’s platform is compliant with federal medical HIPAA rules for patient privacy, he added.  

Memora Health is an example of a growing trend in health care–focused startups using A.I. to help streamline patient care that can often overwhelm time-crunched physicians. The startup Ada, for instance, built a chatbot that people can use to ask about symptoms they are experiencing.   

Andreessen Horowitz partner Dr. Vineeta Agarwala, who joined Memora’s board as part of the latest funding round, explained that Memora is attempting to help patients receive better care from their health care providers. Often, patients leave hospitals feeling disconnected from their physicians.

“I could have had a stroke, and no one knows,” Agarwala said.

She said that Memora Health stood out because it had already attracted some notable customers—Mayo Clinic, the Dana-Farber Cancer Institute, and Banner Health among them—and had developed a product that doctors actually used. Many health care startups create products that use interesting technology, but that don’t actually help physicians do their jobs better. 

Because it relies so much on health care data, or electronic health records, to power its software, Memora Health could compete in the future against health record giants like Epic Systems. But that’s only if those companies build similar analytic software to accompany their database services. 

Agarwala dismissed that concern, however.

“These digital records companies are just no longer the most innovative companies,” she said.

More must-read tech coverage from Fortune:

  • What percentage of unicorns fail?
  • A new cryptocurrency claims to be an eco-friendly Bitcoin alternative. Is chia worth a look?
  • New European regulations require tech companies to prove A.I. is trustworthy
  • Ransomware attackers see a big target in Big Energy
  • This is how the global chip shortage will end

Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today.
About the Author
By Jonathan Vanian
LinkedIn iconTwitter icon

Jonathan Vanian is a former Fortune reporter. He covered business technology, cybersecurity, artificial intelligence, data privacy, and other topics.

See full bioRight Arrow Button Icon

Latest in Tech

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Tech

AITech
Anthropic’s Claude overtakes ChatGPT in App Store as users boycott over OpenAI’s $200 million Pentagon contract
By Marco Quiroz-GutierrezMarch 2, 2026
5 minutes ago
dave ricks
AIScience
Tech giants see a cure for cancer in AI. But Eli Lilly’s CEO finds it ‘not particularly good’ at solving biology or chemistry problems
By Jake AngeloMarch 2, 2026
23 minutes ago
Photo of a young man holding a smartphone having his face scanned
LawSocial Media
Social media companies are fighting the ‘age verification trap’ as collecting biometrics on kids violates privacy rights
By Catherina GioinoMarch 2, 2026
2 hours ago
OpenAI CEO Sam Altman
AIOpenAI
OpenAI CEO Sam Altman defends decision to strike Pentagon deal after Anthropic blacklisting, admits ‘optics don’t look good’
By Jeremy KahnMarch 2, 2026
2 hours ago
greenspan
EconomyFederal Reserve
’90s nostalgia seizes the Fed and White House as Warsh and Trump see AI as an internet-style productivity boom
By Paul Wiseman and The Associated PressMarch 2, 2026
5 hours ago
washington
LawWashington
Washington roasted for using AI feature with heavily accented English instead of actual Spanish on state helpline
By Cedar Attanasio and The Associated PressMarch 2, 2026
6 hours ago

Most Popular

placeholder alt text
Economy
Your grandparents are the reason the U.S. isn't in a recession right now. That won't last forever
By Eleanor PringleMarch 1, 2026
1 day ago
placeholder alt text
Success
MacKenzie Scott's close relationship with Toni Morrison long before Amazon put Scott on the path to give more than $1 billion to HBCUs
By Sasha RogelbergMarch 1, 2026
1 day ago
placeholder alt text
Middle East
U.S. military gives Iran a taste of its own medicine with cheap copycat Shahed drones, while concern shifts to munitions supply in extended conflict
By Jason MaMarch 1, 2026
23 hours ago
placeholder alt text
Middle East
As Iran attacks Dubai, the tax-free haven for the global elite could see 'catastrophic' fallout — 'this can also send shockwaves globally'
By Jason MaMarch 1, 2026
1 day ago
placeholder alt text
AI
American schools weren’t broken until Silicon Valley used a lie to convince them they were—now reading and math scores are plummeting
By Sasha RogelbergMarch 1, 2026
23 hours ago
placeholder alt text
Health
Gen Z men are eating ‘boy kibble,’ the human equivalent to dog food, to load up on protein cheaply
By Jake AngeloMarch 1, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.